Lorusso, Vito
 Distribuzione geografica
Continente #
NA - Nord America 328
EU - Europa 216
AS - Asia 35
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 581
Nazione #
US - Stati Uniti d'America 327
PL - Polonia 126
SE - Svezia 34
CN - Cina 21
IT - Italia 18
DE - Germania 8
IE - Irlanda 8
FR - Francia 7
GB - Regno Unito 7
TR - Turchia 6
UA - Ucraina 4
VN - Vietnam 4
FI - Finlandia 3
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
MY - Malesia 1
PA - Panama 1
Totale 581
Città #
Warsaw 126
Fairfield 53
Chandler 48
Ashburn 26
Woodbridge 21
Cambridge 16
Ann Arbor 15
Houston 15
Seattle 14
Wilmington 13
Jacksonville 9
Dublin 8
Nanjing 7
Beijing 6
Dearborn 6
Izmir 5
Marseille 5
Boston 4
Dong Ket 4
New York 4
Redmond 4
San Mateo 4
Cattolica 3
London 3
Princeton 3
Redwood City 3
Boardman 2
Chicago 2
Jiaxing 2
Lancaster 2
Lawrence 2
Mountain View 2
Nanchang 2
Rome 2
Abidjan 1
Bremen 1
Changsha 1
Fonte Nuova 1
Fucecchio 1
Hebei 1
Hefei 1
Helsinki 1
Indiana 1
Kocaeli 1
Kuala Lumpur 1
Las Vegas 1
Nürnberg 1
Panama City 1
Phoenix 1
San Diego 1
San Francisco 1
Segrate 1
Simi Valley 1
Tianjin 1
Totale 461
Nome #
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 264
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 154
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 79
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma 55
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 34
Totale 586
Categoria #
all - tutte 1.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 14 7
2019/2020126 14 8 13 22 9 10 14 5 8 6 9 8
2020/2021142 7 43 2 12 15 9 17 2 9 14 6 6
2021/202256 8 10 0 0 4 1 5 5 2 4 10 7
2022/2023121 17 14 7 19 5 17 6 10 15 1 3 7
2023/202424 1 14 0 2 0 5 1 0 1 0 0 0
Totale 586